Issue 17, 2023

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases

Abstract

Magnetic nanoparticles possess unique properties distinct from other types of nanoparticles developed for biomedical applications. Their unique magnetic properties and multifunctionalities are especially beneficial for central nervous system (CNS) disease therapy and diagnostics, as well as targeted and personalized applications using image-guided therapy and theranostics. This review discusses the recent development of magnetic nanoparticles for CNS applications, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and drug addiction. Machine learning (ML) methods are increasingly applied towards the processing, optimization and development of nanomaterials. By using data-driven approach, ML has the potential to bridge the gap between basic research and clinical research. We review ML approaches used within the various stages of nanomedicine development, from nanoparticle synthesis and characterization to performance prediction and disease diagnosis.

Graphical abstract: Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases

Article information

Article type
Review Article
Submitted
21 мар. 2023
Accepted
24 јул. 2023
First published
28 јул. 2023
This article is Open Access
Creative Commons BY-NC license

Nanoscale Adv., 2023,5, 4354-4367

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases

A. Tomitaka, A. Vashist, N. Kolishetti and M. Nair, Nanoscale Adv., 2023, 5, 4354 DOI: 10.1039/D3NA00180F

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements